相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia
Francesca Lorentino et al.
LEUKEMIA (2021)
Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation
Muhammad Bilal Abid et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation
Remy Dulery et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression
Lucas P. Wachsmuth et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Clinical Impacts of Using Serum IL-6 Level as an Indicator of Cytokine Release Syndrome after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide
Mitsutaka Nishimoto et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation
Giorgia Battipaglia et al.
BLOOD (2019)
Sequential Conditioning with Thiotepa in T Cell-Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors
Remy Dulery et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study
Adrien Picod et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Single Antigen-Mismatched Unrelated Hematopoietic Stem Cell Transplantation Using High-Dose Post-Transplantation Cyclophosphamide Is a Suitable Alternative for Patients Lacking HLA-Matched Donors
Ana Sofia Jorge et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
Jordan Gauthier et al.
BONE MARROW TRANSPLANTATION (2018)
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
Annalisa Ruggeri et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia
Mohamad Mohty et al.
HAEMATOLOGICA (2017)
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia
Mohamad Mohty et al.
HAEMATOLOGICA (2017)
Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
Carmen Martinez et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report
J. R. Passweg et al.
BONE MARROW TRANSPLANTATION (2017)
Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission
A. Ruggeri et al.
BONE MARROW TRANSPLANTATION (2016)
Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?
O. Ringden et al.
LEUKEMIA (2016)
The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT)
Shinya Ishida et al.
ANNALS OF HEMATOLOGY (2016)
Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C,-DRB1, and-DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index
Asad Bashey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation
M. Mielcarek et al.
BLOOD (2016)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Madan H. Jagasia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Stefan O. Ciurea et al.
BLOOD (2015)
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia
A. Ruggeri et al.
LEUKEMIA (2015)
Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling Grafts
Anna Maria Raiola et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Juan Carlos Plana et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2014)
Cardioprotective effect of Saraca indica against cyclophosphamide induced cardiotoxicity in rats: A biochemical, electrocardiographic and histopathological study
A. H. M. Viswanatha Swamy et al.
INDIAN JOURNAL OF PHARMACOLOGY (2013)
A disease risk index for patients undergoing allogeneic stem cell transplantation
Philippe Armand et al.
BLOOD (2012)
Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation
Eric J. Chow et al.
ANNALS OF INTERNAL MEDICINE (2011)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Late cardiovascular events after allogeneic hematopoietic stem cell transplantation:: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation
Andre Tichelli et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
Smita Bhatia et al.
BLOOD (2007)
Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation
Andre Tichelli et al.
BLOOD (2007)
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid et al.
BLOOD (2006)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Cardiac toxicity of high-dose chemotherapy
P Morandi et al.
BONE MARROW TRANSPLANTATION (2005)
分享论文
